ARTICLE | Clinical News
AnergiX: ANRG began Phase I testing
July 13, 1998 7:00 AM UTC
Anergen Inc. (ANRG), Redwood City, Calif. Product: AnergiX peptide from cartilage-derived glycoprotein HCgp39 Indication: Treat rheumatoid arthritis Status: ANRG began Phase I testing in patients with...